Search


	Podcast:		OncLive® On Air
	Episode:		24: Talking KRAS-Targeted Therapy in NSCLC With Dr. Riess
	Category:		Science & Medicine
	Duration:		00:11:14
	Publish Date:		2020-07-27 14:00:00
	Description:		In our exclusive interview, Dr. Riess discussed the excitement surrounding KRAS G12C inhibitors in NSCLC, preliminary efficacy and safety data with AMG 510, and additional research regarding co-mutations and combinations that could lead to further refinement of the potential role of the agent in the landscape.
	Total Play:		0